中文版
Application List
 
No. Name Institution Project Name Patient No. Approval date
103001 Lin-Tsing Chen Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital Tumor Biology of Hepatocellular Carcinoma 90 20141226
104002 Su-Fang Lin National Institute of Cancer Research, National Health Research Institutes, Taiwan FGFR2 gene fusion in Taiwanese intrahepatic cholangiocarcinoma tissues 90 20150306
104003 Yoa-Pu Hu Department of Pharmacy, National Defense Medical Center Function and expression of drug transporters dictate the different rosuvastatin systemic exposure between Asians and Caucasians 40 20150508
104004 Dar-In Tai Gastroenterology and hepatology, Chang Gung Memorial Hospital Human genetic polymorphism in therapeutic response of chronic hepatitis B 1000 20150731
104005 Sen-Yung Hsieh Chang Gung Memorial Hospital In vivo functional genomics to decipher the genes/mechanisms orchestrating hepatoma invasion 180 20150731
104006 Yun-Ru Liu Joint Biobank, Taipei Medical University The association analysis of a histone mRNA as a new biomarker of HCC recurrence 92 20151005
104007 Hsu Shih-Hsien KMU To explore the regulatory effect of aryl hydrocarbon receptor (AhR) on initiation and enhance role of oncoprotein ISX in human hepatocellular carcinoma (HCC) 200 20151005
104008 Pei-Jer Chen Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Development of new treatment and biomarker for hepatocellular carcinoma: from woodchuck to human (3/3) 120 20151005
104009 Wan-long Chuang Kaohsiung Medical University
Chung-Ho Memorial Hospital
HCV infection affects on growth hormone signaling pathway in liver diseases and hepatocellular carcinoma progression 200 20151207
105010 Yi-Hsiang Liu
Chiung-Chi Cheng
Chang Bing Show Chwan Memorial Hospital Differential expression of the cytoskeleton proteins and the plectin in human hepatocellular carcinoma versus liver cells and in cholangicarcinoma versus bile duct epithelium 120 20160121
105011 Yuh-Shan Jou Institute of Biomedical Sciences ,Academia Sinica Dissecting molecular mechanisms of PSPC1 overexpression driven cancer EMT, stemness and tumor metastasis. 200 20160121
105012 Pei-Jer Chen Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Development of new treatment and biomarker for hepatocellular carcinoma: from woodchuck to human (3/3) 120 20160121
105013 Yi-Hsiang Huang Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital The Role of Tid1 Expression in Behavior and Prognosis of hepatocellular Carcinoma 200 20160325
105014 Chiun Hsu National Taiwan University Hospital Incorporation of genomic and immunological studies for biomarker identification for hepatocellular carcinoma 600 20160325
105015 Jui-Hsiang Hung Department of Biotechnology, Chia Nan University of Pharmacy and Science To investigate the effect of nucleobindin-2 overexpression by endoplasmic reticulum stress on hepatocellular carcinoma treatment 120 20160503
105016 Kwang-Huei Lin Graduate Institutes of Biomedical Sciences, Chang Gung University Characterization the physiological significance of angiogenesis associated gene regulated thyroid hormone 160 20160503
105017 Shih-Feng Tsai Institute of Molecular and Genomic Medicine, National Health Research Institutes Translational research on genomic variations in liver cancer 250 20160503
105018 Alice L. Yu Institute of Stem Cell and Translational Cancer Research, Linkou Chang Gung Memorial Hospital Tumor Biology of Hepatocellular carcinoma 90 20160725
105019 I-Cheng Lee Division of Gastroenterology and Hepatology, Department of Medicine ,Taipei Veterans General Hospital The Role of Host Immune Regulators and Tumor Microenvironment in the Prognosis of Hepatocellular Carcinoma 200 20160919
105020 Yu-Tsung Shih Institute of Cellular and System medicine, National Health Research Institutes Unrevealing the Metabolic Abnormalities of Endothelial Cells in Response to the Angiogenic Niche Composed by Endothelial Progenitors and Hepatocarcinoma Cells 24 20160919
105021 Shiou-Hwei Yeh Dept. of Microbiology, College of Medicine, National Taiwan University The distribution trend of Glypican-3 expression in hepatocellular carcinoma 120 20160919
105022 Li Ching Li Shuang Ho Hospital, Taipei Medical University Investigation of nicotine/cigarette-smoke promotes metastasis of hepatocellular carcinoma through nAChR and pre-clinically evaluation of correlation between smoking and hepatocellular carcinoma 180 20161128
105023 Chiun Hsu National Taiwan University Hospital Incorporation of genomic and immunological studies for biomarker identification for hepatocellular carcinoma 800 20161128
106024 Hsieh, Shie-Liang Genomics Research Center, Academia Sinica Liver and plasma C-type lectin 18 (CLEC18) expression in hepatitis B and C virus infected patients 260 20170209
106025 Hsiung, Chao Agnes Institute of Population Health Sciences, National Health Research Institutes Using EGFR mutation status and germline genetic variants jointly to make decision for treating late-stage lung adenocarcinoma patients - a prospective study 220 20170209
106026 Yi-mimg Chen Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University A study of the epigenetic regulation of GNMT gene expression and the role GNMT plays in the control of global DNA methylation 80 20170209
106027 Jung-Jyh Hung Division of Thoracic Surgery, Taipei Veterans General Hospital Identification of genes related to metastasis and their regulating mechanisms in lung cancer by combination of pathological subtypes and gene expression in microarray (II) 120 20170209
106028 Pei-Jer Chen Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University Taiwan Research Biosignature Network on Patients at High Risk of Hepatocellular Carcinoma (TARGET-HCC) 60 20170419
106029 Hsien-Chung Yu Division of Gastroenterology and Hepatobiliary, Department of Internal Medicine, Kaohsiung Veterans General Hospital The correlation between serum BioFibroScore, Pre-S Deletion and Histological Fibrosis in Chronic Hepatitis B Patients with Hepatocellular Carcinoma Receiving Curative Resection 150 20170419
106030 Tung-Hung Su Internal Medicine, National Taiwan University Hospital Clinical implications of immunophenotypes in liver fibrosis and hepatocellular carcinoma 150 20170612
106031 Shih-Feng Tsai Institute of Molecular and Genomic Medicine, National Health Research Institutes Flagship program of precision medicine for Asiapacific Biomedical Silicon Valley 200 20170811
106032 Chau-Ting Yeh Liver Research Center, Chang-Gung Memorial Hospital Clinical and molecular characterization of hepatocellular carcinoma carrying distinct patterns of HBV S gene truncation mutations 11 20170612
106033 Yan-Hwa Wu Lee Department of Biological Science and Technology, National Chiao-Tung University Functional roles of DDX3 in regulating exosome biogenesis and its therapeutic potential on hepatic tumorigenesis 75 20170811
106034 Chau-Ting Yeh Liver Research Center, Chang-Gung Memorial Hospital Clinical and molecular characterization of hepatocellular carcinoma carrying distinct patterns of HBV S gene truncation mutations 200 20170811
106035 Chia-Hung Yen Graduate Institute of Natural Products, Kaohsiung Medical University A study of the role of redox state in the development of sarcomatoid hepatocellular carcinoma and its application in antiliver cancer drug discovery 120 20171020
106036 Jun-Yang Liou Institute of Cellular and System Medicine, National Health Research Institutes To investigate the role of AKR1B10 expression and metabolism in regulating epithelial-mesenchymal transition and drug resistance of hepatocellular carcinoma 150 20171222
106037 Li-Fen Shen Drug Development Division, TaiRx,Inc A Pilot Study of Tumor Prognostic Biomarker in Hepatocellular Carcinoma 120 20180205
106038 Jun-Yang Liou Institute of Cellular and System Medicine, National Health Research Institutes To investigate the role of AKR1B10 expression and metabolism in regulating epithelial-mesenchymal transition and drug resistance of hepatocellular carcinoma 150 20180205
107039 Jyh-Lyh Juang Institute of Molecular and Genomic Medicine,National Health Research Institutes Identification of potential mechanism for liver cancer in tumor tissue 50 20180409
107040 Mei-Hwei Chang Pediatrics,National Taiwan University College of Medicine Long-term Follow-up of Chronic Hepatitis B Virus Infection from Mother-to-Infant Transmission to Adult Life 50 20180409
107041 Jinn-Moon Yang Institute of Bioinformatics and System Biology,National Chiao Tung Tung University Intelligent Computing Precision Medical and Drug Development Platform – Integrated dynamic systems biology models to study the mechanisms between diabetes mellitus and liver cancer for developing biomarkers and drugs 120 20180409
107042 Yan-Hwa Wu Lee Department of Biological Science and Technology, National ChiaoTung University Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B 30 20180409
107043 Yue-Liang Guo National Institute of Environmental Health sciences,National Health Research Institute Air pollutants and hepatocellular carcinoma survival 1000 20180927
107044 Jui-Hsiang Hung Department of Biotechnology,Chia Nan University of Pharmacy and Science To investigate the mechanism of endoplasmic reticulum stress-induced nucleobindin-2 expression and its effect on the treatment of liver cancer 120 20180626
107045 Pei-Jer Chen Graduate institute of Clinical Medicine,College of Medicine,National Taiwan University Taiwan Research Biosignature Network on Patients at High Risk of Hepatocellular Carcinoma(TARGET-HCC) 50 20180626
107046 Hsu Shih-Hsien Graduate Institute of Medicine,Kaohsiung Medical University To explore the potential regulatory mechanism and clinical outcomes of epigenetic modulator, PCAF, on oncogenic transcriptional complex, ISX-Brd4-RNA pol II complex in lung cancer 50 20180829
107047 Hsiung CA Institute of Population Health Sciences,National Health Research Institutes Biomarker Development for Lung Adenocarcinoma Risk Prediction and Drug Response 300 20180829
107048 Jyh-Lyh Juang Institute of Molecular and Genomic Medicine, National Health Research Institutes Indentification of potential mechanism for liver cancer in tumor tissue 40 20181220
107049 Mei-Hwei Chang Pediatrics,National Taiwan University College of Medicine Long-term Follow-up of Chronic Hepatitis B Virus Infection from Mother-to-Infant Transmission to Adult Life 150 20181220
107050 Ma,Wen-Lung Graduate Institute of BioMedical Sciences,China medical university Study of the metabolic syndrome-related VLDL and VLDLR roles in hepatocellular carcinoma 225 20181220
108051 Tzu-Ling Tseng Bio Preventive Medicine Corp. Cancer biomarkers development 60 20190227
108052 Chi-Ying Huang Institute of Biopharmaceutical Sciences,National Yang-Ming University The prognostic correlation of exosomal GPC3 level at diagnosis,surveillance and survival of patients with hepatocellular carcinoma 50 20190227
108053 Chao-Wei Hsu Division of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital Clinical and Functional Significance of infections of Genetically Different Hepatitis Delta Virus 300 20190227
108054 Mei-Hwei Chang Pediatric,National Taiwan University College of Medicine Long-term Follow-up of Chronic Hepatitis B Virus Infection from Mother-to-Infant Transmission to Adult Life 100 20190227
108055 Yan-Hwa Wu Lee Department of Biological Science and Technology, National Chiao Tung University Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B 50 20190424
108056 Shih-Feng Tsai Institute of Molecular and Genomic Medicine, National Health Research Institutes Translational research on genomic variations in liver cancer 150 20190424
108057 Ling-Yueh Hu Laboratory of Translational Medicine Office, Development Center for Biotechnology Explore the expression and distribution of the immune checkpoint related proteins in normal liver tissue 40 20190625
108058 George Wei Clinical Project Management Dep. ACT Genomics Co., Ltd. To Study the Association between Mutational Spectrum/Tumor Microenvironment and Prognosis in HCC/CC Using Archived Specimens 300 20190625
108059 Ting-Fen Tsai Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University Development of novel therapeutics for non-alcoholic fatty liver diseases (NAFLD) and steatohepatitis (NASH) 170 20190820
108060 Yang-Hsiang Lin Liver Research Center, Chang Gung Memorial Hospital, Linkou Characterization of LOC731656 functions in human hepatocellular carcinoma and its clinical significance 80 20190820
108061 Lee, Mei-Hsuan Institute of Clinical Medicine, National Yang Ming University DNA methylation profiling, antigen representation of HLA and associated risk for hepatocellular carcinoma 900 20191007
108062 Sen-Yung Hsieh Dept. of Gastroenterology & Hepatology, Linkou Chang Gung Memorial Hospital Decipher genomic and epigenomic alternations in the liver and digestive cancers 108 20191007
108063 Yan-Hwa Wu Lee Department of Biological Science and Technology, National Chiao Tung University Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B 30 20191213
公告日:2019/12/17



Copyright © 2017 National Health Research Institutes Biobank
35 Keyan Road,Zhunan,Miaoli 35053,Taiwan,R.O.C. / Tel : +886-37-206166 ext 33328 / Service Time: Monday to Friday 9:00 to 18:00